-- 
Novo Nordisk Files for U.S. Approval of Degludec, DegludecPlus

-- B y   C h r i s t i a n   W i e n b e r g
-- 
2011-09-29T20:09:38Z

-- http://www.bloomberg.com/news/2011-09-29/novo-nordisk-files-for-u-s-approval-of-degludec-degludecplus.html
Novo Nordisk A/S said it has
submitted to the U.S. Food and Drug Administration two new drug
applications for the approval of ultra-longacting insulin
Degludec and the insulin combination analogue DegludecPlus,
respectively.  To contact the editor responsible for this story:
Christian Wienberg at 
 cwienberg@bloomberg.net  